The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis

被引:360
作者
Tobon, Gabriel J.
Youinou, Pierre
Saraux, Alain
机构
[1] Univ Bretagne Occidentale, IFR 148, EA2216, Brest, France
[2] Ctr Hosp Univ Brest, Serv Rhumatol, Brest, France
关键词
Rheumatoid arthritis; Epidemiology; Incidence; Prevalence; Environmental factors; SHARED EPITOPE; UNITED-KINGDOM; PREVALENCE; RISK; POPULATION; PTPN22; SUSCEPTIBILITY; POLYMORPHISMS; MORTALITY; BRITTANY;
D O I
10.1016/j.jaut.2009.12.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rheumatoid arthritis (RA) is a chronic inflammatory joint disease characterized by a distinctive pattern of bone and joint destruction. RA patients have an increased risk of death. The incidence and prevalence of RA vary across populations, statistical methods, and disease definitions. In North America and Northern Europe, the incidence of RA is estimated at 20-50 cases per 100,000 population and the prevalence at 0.5-1.1%. Lower incidences and prevalences have been reported in Southern Europe, and few data are available for developing countries. Some studies showed declining incidences and prevalences after the 1960s. RA is a multifactorial disease that results from interactions between genetic and environmental factors. The main genetic factors are HLA-DRB1 and the tyrosine-phosphatase gene PTPN22. Among environmental factors implicated in the development of RA, smoking shows the strongest association with RA susceptibility and is also linked to worse outcomes. The aim of this review is to discuss the available data on the incidence and prevalence of RA, as well as the genetic and environmental risk factors associated with RA. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:10 / 14
页数:5
相关论文
共 40 条
[31]   STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus [J].
Remmers, Elaine F. ;
Plenge, Robert M. ;
Lee, Annette T. ;
Graham, Robert R. ;
Hom, Geoffrey ;
Behrens, Timothy W. ;
de Bakker, Paul I. W. ;
Le, Julie M. ;
Lee, Hye-Soon ;
Batliwalla, Franak ;
Li, Wentian ;
Masters, Seth L. ;
Booty, Matthew G. ;
Carulli, John P. ;
Padyukov, Leonid ;
Alfredsson, Lars ;
Klareskog, Lars ;
Chen, Wei V. ;
Amos, Christopher I. ;
Criswell, Lindsey A. ;
Seldin, Michael F. ;
Kastner, Daniel L. ;
Gregersen, Peter K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (10) :977-986
[32]   Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials [J].
Salliot, C. ;
Dougados, M. ;
Gossec, L. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (01) :25-32
[33]  
Saraux A, 1999, J RHEUMATOL, V26, P2622
[34]  
Savolainen E, 2003, J RHEUMATOL, V30, P2460
[35]   Cigarette smoking increases the risk of rheumatoid arthritis - Results from a nationwide study of disease-discordant twins [J].
Silman, AJ ;
Newman, J ;
MacGregor, AJ .
ARTHRITIS AND RHEUMATISM, 1996, 39 (05) :732-735
[36]  
SILMAN AJ, 1993, J RHEUMATOL, V20, P618
[37]  
Spindler A, 2002, J RHEUMATOL, V29, P1166
[38]   The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century [J].
Symmons, D ;
Turner, G ;
Webb, R ;
Asten, P ;
Barrett, E ;
Lunt, M ;
Scott, D ;
Silman, A .
RHEUMATOLOGY, 2002, 41 (07) :793-800
[39]  
SYMMONS DPM, 1994, BRIT J RHEUMATOL, V33, P735
[40]   Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis [J].
van Venrooij, Walther J. ;
Zendman, Albert J. W. ;
Pruijn, Ger J. M. .
AUTOIMMUNITY REVIEWS, 2006, 6 (01) :37-41